Riverstone Holdings (AP4.SI, SES) S$0.78 after hours 18 Feb 2026: earnings preview

AP4.SI stock trades at S$0.775 after hours on 18 Feb 2026, up 1.97% from the session close as investors position ahead of Riverstone Holdings Limited’s earnings announcement on 23 Feb 2026. Riverstone (AP4.SI) reports modest trailing metrics: EPS S$0.05 and PE 15.50, with FY2024 revenue growth of 17.28%. We focus on earnings drivers, dividend sustainability, and how guidance could move the stock on the SES in Singapore.

Earnings outlook for AP4.SI stock

Riverstone Holdings (AP4.SI) will report results on 23 Feb 2026. Consensus details are thin, but trailing EPS is S$0.05 and fiscal revenue grew 17.28% in 2024. Management commentary on rubber and nitrile glove volumes and cleanroom sales should guide margins and revenue mix.

Price action and technicals for AP4.SI stock

The share sits at S$0.775 with a day range of S$0.76–S$0.78 and volume 1,225,300 versus average 2,662,426. Short-term momentum is muted: RSI 40.46 and MACD roughly flat. The 50-day average S$0.8437 is above price, while the 200-day S$0.77263 is near current levels, signalling mixed medium-term bias.

Valuation, cash flow and dividend signals for AP4.SI stock

AP4.SI trades at PE 15.50 and PB 2.36 with strong liquidity: current ratio 9.18 and cash per share S$0.45. The company paid dividend per share S$0.2322, a yield of 9.71%, but payout ratio is 152.28%, which raises sustainability concerns if cash flow weakens. Free cash flow per share is S$0.13, supporting dividends for now but meriting scrutiny in the report.

Meyka AI grade and forecast for AP4.SI stock

Meyka AI rates AP4.SI with a score out of 100: 71.74 (Grade B+, Suggestion: BUY). This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. The grade is informational only and not investment advice.

Meyka AI’s forecast model projects monthly S$0.68, quarterly S$0.63, and yearly S$0.73615. Compared with the current S$0.775, the model implies near-term downside of -12.26% (monthly) and a yearly downside of -5.01%. Forecasts are model-based projections and not guarantees.

Sector context, risks and opportunities for AP4.SI stock

Riverstone operates in Healthcare, Medical Instruments & Supplies, where Singapore healthcare peers trade higher on growth. Key opportunities: stronger cleanroom demand from semiconductor customers and recovery in nitrile glove pricing. Key risks: raw material cost swings, high dividend payout ratio and volume softness that could hit margins.

Price targets and trading strategy for AP4.SI stock

We frame three pragmatic price targets in SGD on the SES: conservative S$0.65, base S$0.78, optimistic S$1.05 (near the 52-week high). Short-term traders should watch the earnings beat/miss and dividend commentary. Longer-term investors should track free cash flow and order-book trends before adding exposure.

Final Thoughts

AP4.SI stock is trading at S$0.775 after hours on 18 Feb 2026 as the market awaits Riverstone Holdings’ 23 Feb 2026 earnings. The company shows healthy margins (operating margin ~27.67%) and strong liquidity (current ratio 9.18), but the high payout ratio 152.28% makes the 9.71% yield conditional on continued cash generation. Meyka AI’s forecast model projects a yearly price near S$0.73615, implying a -5.01% move from today’s price, while a monthly read suggests a deeper pullback to S$0.68. Our blended price target range is S$0.65–S$1.05, with a base case at S$0.78. Investors should use the earnings release to confirm demand trends for cleanroom and glove segments, and validate dividend coverage from free cash flow. Meyka AI provides this AI-powered market analysis as a data-driven input; forecasts are model-based and not guarantees. Watch guidance and order-book details for the clearest short-term signal.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.